首页 > 最新文献

Journal of Infection and Chemotherapy最新文献

英文 中文
Prosthetic stent graft infection caused by Aerococcus urinae: A case report and literature review. 由尿道气球菌引起的人工支架移植物感染:病例报告和文献综述。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-11-01 DOI: 10.1016/j.jiac.2024.10.018
Shion Maruyama, Toshinori Nishizawa, Kazuhiro Ishikawa, Tomu Sato, Kuniko Sato, Gautam A Deshpande, Hiroko Arioka

Aerococcus urinae, a gram-positive, catalase-negative coccus, has emerged as a notable pathogen in clinical microbiology. It is traditionally associated with urinary tract infections in elderly males with underlying urologic conditions. Recently, A. urinae has been implicated in severe invasive infections outside the genitourinary tract including infective endocarditis, vertebral osteomyelitis, peritonitis, lymphadenitis, and discitis. We present the case of 84-year-old male with a history of aortic graft replacement who presented with five days of fever and fatigue. Blood and urine cultures grew gram-positive cocci, identified as A. urinae. Thoracoabdominal contrast-enhanced CT revealed a slightly increased soft tissue shadowing around the prosthetic stent in the ascending aorta, indicating a possible aortic stent-graft infection. Gallium-67 scintigraphy demonstrated inflammation around the prosthetic stent in the ascending aorta consistent with an aortic stent-graft infection. The patient and family opted for conservative treatment and despite a six-week inpatient course of ampicillin, followed by oral amoxicillin, the patient died one week after discharge. This is the first published case of A. urinae causing an aortic stent-graft infection. Clinicians should remain cognizant of the disseminated source of infection in cases of A. urinae bacteremia.

尿道气球菌(Aerococcus urinae)是一种革兰氏阳性、过氧化氢酶阴性球菌,已成为临床微生物学中的一种重要病原体。传统上,它与患有潜在泌尿系统疾病的老年男性的尿路感染有关。最近,A. urinae 又与泌尿生殖道以外的严重侵袭性感染有关,包括感染性心内膜炎、脊椎骨髓炎、腹膜炎、淋巴结炎和椎间盘炎。我们介绍了一例 84 岁的男性病例,他有主动脉移植置换术史,因发热和乏力就诊五天。血液和尿液培养均检出革兰氏阳性球菌,确定为 A. urinae。胸腹对比增强 CT 显示升主动脉人工支架周围的软组织阴影略有增加,表明可能发生了主动脉支架移植物感染。镓-67闪烁扫描显示升主动脉人工支架周围存在炎症,与主动脉支架移植物感染一致。患者和家属选择了保守治疗,尽管住院期间服用了六周的氨苄西林,随后又口服了阿莫西林,但患者还是在出院一周后死亡。这是第一例公开发表的由 A. urinae 引起的主动脉支架移植感染病例。临床医生应时刻警惕尿囊菌血症病例中的传播感染源。
{"title":"Prosthetic stent graft infection caused by Aerococcus urinae: A case report and literature review.","authors":"Shion Maruyama, Toshinori Nishizawa, Kazuhiro Ishikawa, Tomu Sato, Kuniko Sato, Gautam A Deshpande, Hiroko Arioka","doi":"10.1016/j.jiac.2024.10.018","DOIUrl":"10.1016/j.jiac.2024.10.018","url":null,"abstract":"<p><p>Aerococcus urinae, a gram-positive, catalase-negative coccus, has emerged as a notable pathogen in clinical microbiology. It is traditionally associated with urinary tract infections in elderly males with underlying urologic conditions. Recently, A. urinae has been implicated in severe invasive infections outside the genitourinary tract including infective endocarditis, vertebral osteomyelitis, peritonitis, lymphadenitis, and discitis. We present the case of 84-year-old male with a history of aortic graft replacement who presented with five days of fever and fatigue. Blood and urine cultures grew gram-positive cocci, identified as A. urinae. Thoracoabdominal contrast-enhanced CT revealed a slightly increased soft tissue shadowing around the prosthetic stent in the ascending aorta, indicating a possible aortic stent-graft infection. Gallium-67 scintigraphy demonstrated inflammation around the prosthetic stent in the ascending aorta consistent with an aortic stent-graft infection. The patient and family opted for conservative treatment and despite a six-week inpatient course of ampicillin, followed by oral amoxicillin, the patient died one week after discharge. This is the first published case of A. urinae causing an aortic stent-graft infection. Clinicians should remain cognizant of the disseminated source of infection in cases of A. urinae bacteremia.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Studying Abroad on Catch-Up Vaccination in Young Adults: A Study Using the Japan Pretravel Consultation Registry1. 出国留学对年轻人补种疫苗的影响:利用日本旅行前咨询登记处进行的研究1。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-30 DOI: 10.1016/j.jiac.2024.10.015
Nobumasa Okumura, Kei Yamamoto, Noriko Iwamoto, Shinya Tsuzuki, Kenichi Hayashi, Koh Shinohara, Issaku Nakatani, Hidenori Nakagawa, Natsuko Imakita, Takashi Matono, Akihiro Manabe, Tsuyoshi Kitaura, Takahiro Mikawa, Masaya Yamato, Norio Ohmagari

Purpose: To investigate the effect of studying abroad on catch-up vaccination coverage for measles, rubella, mumps, varicella, and tetanus during the pretravel consultation among young adult travelers.

Methods: This retrospective cohort study analyzed data from the Japan Pretravel Consultation Registry (J-PRECOR) on individuals aged 18-21 years with childhood vaccination records. Propensity score weighting was used to estimate the average treatment effect on the proportion of participants receiving catch-up vaccination.

Results: Among 1,091 eligible participants, the catch-up vaccination need was highest for mumps (65.7%) and varicella (49.0%) and lowest for measles (9.9%) and rubella (14.0%). In the unadjusted analysis, the catch-up vaccination rate was 70.6% for tetanus, 50.9% for measles, 47.7% for rubella, 40.0% for mumps, and 23.9% for varicella. In the weighted analysis, the study-abroad group had significantly higher catch-up vaccination rates for measles (54.6% vs. 29.8%, P = 0.039), rubella (53.0% vs. 22.1%, P < 0.001), and varicella (26.8% vs. 10.9%, P = 0.002), whereas the non-study-abroad group had a higher catch-up vaccination rate for tetanus (62.4% vs. 78.4%, P = 0.024).

Conclusion: Compared with other travelers, the catch-up vaccination rate among travelers studying abroad was higher for measles, rubella, and varicella, but lower for tetanus. In clients planning to study abroad, vaccinations required for travel should be recommended in addition to those required by the host institution, and vaccination against highly infectious diseases with potential for complications, such as measles, rubella, mumps, and varicella, should be recommended to clients traveling for reasons other than studying abroad.

目的:研究出国留学对年轻成人旅行者旅行前咨询期间麻疹、风疹、腮腺炎、水痘和破伤风疫苗补种覆盖率的影响:这项回顾性队列研究分析了日本旅行前咨询登记处(J-PRECOR)的数据,研究对象是有儿童疫苗接种记录的 18-21 岁的个人。研究采用倾向得分加权法估算了对接受补种的参与者比例的平均治疗效果:在 1091 名符合条件的参与者中,流行性腮腺炎(65.7%)和水痘(49.0%)的补种需求最高,麻疹(9.9%)和风疹(14.0%)的补种需求最低。在未调整分析中,破伤风的补种率为 70.6%,麻疹为 50.9%,风疹为 47.7%,流行性腮腺炎为 40.0%,水痘为 23.9%。在加权分析中,出国留学组的麻疹(54.6% 对 29.8%,P = 0.039)、风疹(53.0% 对 22.1%,P < 0.001)和水痘(26.8% 对 10.9%,P = 0.002)补种率明显较高,而非出国留学组的破伤风补种率较高(62.4% 对 78.4%,P = 0.024):结论:与其他旅行者相比,出国留学人员的麻疹、风疹和水痘疫苗补种率较高,但破伤风疫苗补种率较低。对于计划出国留学的人,除了建议他们接种所在机构要求的疫苗外,还应建议他们接种旅行所需的疫苗,并建议因留学以外的原因出国的人接种麻疹、风疹、流行性腮腺炎和水痘等可能引起并发症的高传染性疾病的疫苗。
{"title":"Effect of Studying Abroad on Catch-Up Vaccination in Young Adults: A Study Using the Japan Pretravel Consultation Registry<sup>1</sup>.","authors":"Nobumasa Okumura, Kei Yamamoto, Noriko Iwamoto, Shinya Tsuzuki, Kenichi Hayashi, Koh Shinohara, Issaku Nakatani, Hidenori Nakagawa, Natsuko Imakita, Takashi Matono, Akihiro Manabe, Tsuyoshi Kitaura, Takahiro Mikawa, Masaya Yamato, Norio Ohmagari","doi":"10.1016/j.jiac.2024.10.015","DOIUrl":"https://doi.org/10.1016/j.jiac.2024.10.015","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the effect of studying abroad on catch-up vaccination coverage for measles, rubella, mumps, varicella, and tetanus during the pretravel consultation among young adult travelers.</p><p><strong>Methods: </strong>This retrospective cohort study analyzed data from the Japan Pretravel Consultation Registry (J-PRECOR) on individuals aged 18-21 years with childhood vaccination records. Propensity score weighting was used to estimate the average treatment effect on the proportion of participants receiving catch-up vaccination.</p><p><strong>Results: </strong>Among 1,091 eligible participants, the catch-up vaccination need was highest for mumps (65.7%) and varicella (49.0%) and lowest for measles (9.9%) and rubella (14.0%). In the unadjusted analysis, the catch-up vaccination rate was 70.6% for tetanus, 50.9% for measles, 47.7% for rubella, 40.0% for mumps, and 23.9% for varicella. In the weighted analysis, the study-abroad group had significantly higher catch-up vaccination rates for measles (54.6% vs. 29.8%, P = 0.039), rubella (53.0% vs. 22.1%, P < 0.001), and varicella (26.8% vs. 10.9%, P = 0.002), whereas the non-study-abroad group had a higher catch-up vaccination rate for tetanus (62.4% vs. 78.4%, P = 0.024).</p><p><strong>Conclusion: </strong>Compared with other travelers, the catch-up vaccination rate among travelers studying abroad was higher for measles, rubella, and varicella, but lower for tetanus. In clients planning to study abroad, vaccinations required for travel should be recommended in addition to those required by the host institution, and vaccination against highly infectious diseases with potential for complications, such as measles, rubella, mumps, and varicella, should be recommended to clients traveling for reasons other than studying abroad.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of direct identification of bacteria in blood culture-positive specimens by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry on physician selection of antimicrobial therapy. 基质辅助激光解吸附/电离飞行时间质谱法直接鉴定血培养阳性标本中的细菌对医生选择抗菌疗法的影响。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-30 DOI: 10.1016/j.jiac.2024.10.016
Hiroshi Umemura, Hiroyuki Nishiyama, Yumiko Tanimichi, Kohgo Seino, Masaki Nakajima, Sachio Tsuchida, Tomohiro Nakayama

Background: Rapid identification of the causative organism in blood stream infections is essential for early initiation of appropriate antimicrobial therapy. Direct identification of bacteria in positive blood culture bottles using matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry is a promising application. A variety of direct identification methods have been reported; however, few studies have evaluated the impact of these methods on physician decision making regarding antimicrobial therapy.

Methods: We developed a simple method for direct bacterial identification and applied it to daily clinical practice to investigate the impact of direct identification of bacteria in positive blood culture bottles on physicians' choice of antimicrobial agents for treatment.

Results: From January 2016 to December 2022, we attempted direct identification in 98 cases and successfully acquired identification results in 88 cases. In three cases, no empiric antimicrobial agents were initiated at the time of venipuncture for blood culture but later initiated based on the direct identification results. In the remaining 85 cases, empiric antimicrobial therapy was initiated at the time blood cultures were performed, and in 29 cases, empiric antimicrobial therapy was changed after direct identification. In 17 of these 29 cases, the antimicrobial therapy was changed based on the direct identification of bacterial genus/species, resulting in a change to an effective antimicrobial therapy before the antimicrobial susceptibility testing results were available.

Conclusions: Direct identification of bacteria from positive blood culture bottles could contribute to earlier selection of or changes to antimicrobial therapies by attending physicians.

背景:快速鉴定血流感染中的致病菌对于及早启动适当的抗菌治疗至关重要。使用基质辅助激光解吸/电离飞行时间质谱法直接鉴定阳性血培养瓶中的细菌是一种很有前景的应用。目前已报道了多种直接鉴定方法,但很少有研究评估这些方法对医生抗菌治疗决策的影响:方法:我们开发了一种简单的细菌直接鉴定方法,并将其应用于日常临床实践,研究直接鉴定血培养阳性瓶中细菌对医生选择抗菌药物治疗的影响:从2016年1月至2022年12月,我们尝试对98个病例进行直接鉴定,并成功获得88个病例的鉴定结果。在 3 个病例中,静脉穿刺进行血培养时未使用经验性抗菌药物,但后来根据直接鉴定结果使用了抗菌药物。在其余 85 例病例中,经验性抗菌药物治疗是在进行血液培养时启动的,29 例病例的经验性抗菌药物治疗是在直接鉴定后更改的。在这 29 个病例中,有 17 个病例的抗菌治疗是根据细菌属/种的直接鉴定结果而改变的,结果在抗菌药物敏感性检测结果出来之前,就已经改用了有效的抗菌治疗:结论:从阳性血培养瓶中直接鉴定细菌有助于主治医生更早地选择或改变抗菌疗法。
{"title":"Impact of direct identification of bacteria in blood culture-positive specimens by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry on physician selection of antimicrobial therapy.","authors":"Hiroshi Umemura, Hiroyuki Nishiyama, Yumiko Tanimichi, Kohgo Seino, Masaki Nakajima, Sachio Tsuchida, Tomohiro Nakayama","doi":"10.1016/j.jiac.2024.10.016","DOIUrl":"10.1016/j.jiac.2024.10.016","url":null,"abstract":"<p><strong>Background: </strong>Rapid identification of the causative organism in blood stream infections is essential for early initiation of appropriate antimicrobial therapy. Direct identification of bacteria in positive blood culture bottles using matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry is a promising application. A variety of direct identification methods have been reported; however, few studies have evaluated the impact of these methods on physician decision making regarding antimicrobial therapy.</p><p><strong>Methods: </strong>We developed a simple method for direct bacterial identification and applied it to daily clinical practice to investigate the impact of direct identification of bacteria in positive blood culture bottles on physicians' choice of antimicrobial agents for treatment.</p><p><strong>Results: </strong>From January 2016 to December 2022, we attempted direct identification in 98 cases and successfully acquired identification results in 88 cases. In three cases, no empiric antimicrobial agents were initiated at the time of venipuncture for blood culture but later initiated based on the direct identification results. In the remaining 85 cases, empiric antimicrobial therapy was initiated at the time blood cultures were performed, and in 29 cases, empiric antimicrobial therapy was changed after direct identification. In 17 of these 29 cases, the antimicrobial therapy was changed based on the direct identification of bacterial genus/species, resulting in a change to an effective antimicrobial therapy before the antimicrobial susceptibility testing results were available.</p><p><strong>Conclusions: </strong>Direct identification of bacteria from positive blood culture bottles could contribute to earlier selection of or changes to antimicrobial therapies by attending physicians.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the clinical characteristics, laboratory parameters, and antibiotic treatment in patients diagnosed with tularemia. 评估图拉里病毒感染者的临床特征、实验室参数和抗生素治疗。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-29 DOI: 10.1016/j.jiac.2024.10.014
Yasemin Çakır Kıymaz, Serkan Bolat, Bilge Katırcı, Özlem Aldemir, Işık Altınkaya, Merdan Mustafa Özcan, Serhat Murat Hopoğlu, Murtaza Öz, Ertuğrul Keskin, Caner Öksüz, Kübra Fırtına Topçu, Mürşit Hasbek, Halef Okan Doğan, Seyit Ali Büyüktuna, Nazif Elaldı

Introduction: This retrospective, cross-sectional, multi-center study aimed to evaluate the impact of laboratory results and treatments on the treatment response in patients diagnosed with tularemia.

Methods: The study included 190 adult patients diagnosed with tularemia between November 2023 and June 2024.

Results: 67.9 % were female, mean age was 45.8 ± 14.9 years. The most frequently detected symptoms were sore throat (74.2 %), fatigue (71.6 %), and neck swelling (56.3 %). The most common form of tularemia was oropharyngeal (82.6 %) and glandular (14.2 %). The most used monotherapy was ciprofloxacin (80.5 %, n = 136), and combination therapy was streptomycin-ciprofloxacin (81.0 %, n = 17). Treatment failure was observed in 29 patients (15.2 %). No difference was found between patients who responded and didn't respond to treatment regarding laboratory parameters. Lymph node drainage or excision was performed in 47 patients (23 %). Suppurative lymphadenitis, abscess, necrosis, and conglomerate lymphadenopathy were more common in the lymph node drainage group. Reactive lymph nodes were more common in the group without lymph node drainage. There was no difference between the two groups regarding laboratory parameters of patients with and without lymph node drainage. The duration of antibiotic treatment was longer in patients who underwent lymph node drainage than in those who didn't.

Conclusion: Radiological evaluation of lymph nodes upon hospital admission, in addition to antibiotic therapy during treatment, may help predict which patients are more likely to require surgical drainage. Laboratory parameters may not provide significant benefits in predicting the need for lymph node drainage and long-term treatment did not affect the treatment response.

简介:这是一项多中心回顾性横断面研究,旨在评估实验室结果和治疗方法对确诊为土拉菌病患者治疗反应的影响:这项回顾性、横断面、多中心研究旨在评估实验室结果和治疗方法对确诊为土拉菌病患者治疗反应的影响:研究纳入了2023年11月至2024年6月期间确诊为土拉菌病的190名成年患者:67.9%为女性,平均年龄为(45.8±14.9)岁。最常见的症状是喉咙痛(74.2%)、疲劳(71.6%)和颈部肿胀(56.3%)。最常见的土拉菌病是口咽(82.6%)和腺型(14.2%)。最常用的单一疗法是环丙沙星(80.5%,人数=136),联合疗法是链霉素-环丙沙星(81.0%,人数=17)。29名患者(15.2%)治疗失败。在实验室指标方面,对治疗有反应和没有反应的患者之间没有差异。47名患者(23%)进行了淋巴结引流或切除术。在淋巴结引流组中,化脓性淋巴结炎、脓肿、坏死和集合性淋巴结病更为常见。无淋巴结引流组中反应性淋巴结更常见。淋巴结引流组和未引流组患者的实验室指标没有差异。接受淋巴结引流术的患者接受抗生素治疗的时间长于未接受引流术的患者:结论:入院时对淋巴结进行放射学评估,再加上治疗期间的抗生素治疗,可能有助于预测哪些患者更有可能需要手术引流。实验室参数在预测淋巴结引流的必要性方面可能并无明显益处,长期治疗也不会影响治疗反应。
{"title":"Evaluation of the clinical characteristics, laboratory parameters, and antibiotic treatment in patients diagnosed with tularemia.","authors":"Yasemin Çakır Kıymaz, Serkan Bolat, Bilge Katırcı, Özlem Aldemir, Işık Altınkaya, Merdan Mustafa Özcan, Serhat Murat Hopoğlu, Murtaza Öz, Ertuğrul Keskin, Caner Öksüz, Kübra Fırtına Topçu, Mürşit Hasbek, Halef Okan Doğan, Seyit Ali Büyüktuna, Nazif Elaldı","doi":"10.1016/j.jiac.2024.10.014","DOIUrl":"10.1016/j.jiac.2024.10.014","url":null,"abstract":"<p><strong>Introduction: </strong>This retrospective, cross-sectional, multi-center study aimed to evaluate the impact of laboratory results and treatments on the treatment response in patients diagnosed with tularemia.</p><p><strong>Methods: </strong>The study included 190 adult patients diagnosed with tularemia between November 2023 and June 2024.</p><p><strong>Results: </strong>67.9 % were female, mean age was 45.8 ± 14.9 years. The most frequently detected symptoms were sore throat (74.2 %), fatigue (71.6 %), and neck swelling (56.3 %). The most common form of tularemia was oropharyngeal (82.6 %) and glandular (14.2 %). The most used monotherapy was ciprofloxacin (80.5 %, n = 136), and combination therapy was streptomycin-ciprofloxacin (81.0 %, n = 17). Treatment failure was observed in 29 patients (15.2 %). No difference was found between patients who responded and didn't respond to treatment regarding laboratory parameters. Lymph node drainage or excision was performed in 47 patients (23 %). Suppurative lymphadenitis, abscess, necrosis, and conglomerate lymphadenopathy were more common in the lymph node drainage group. Reactive lymph nodes were more common in the group without lymph node drainage. There was no difference between the two groups regarding laboratory parameters of patients with and without lymph node drainage. The duration of antibiotic treatment was longer in patients who underwent lymph node drainage than in those who didn't.</p><p><strong>Conclusion: </strong>Radiological evaluation of lymph nodes upon hospital admission, in addition to antibiotic therapy during treatment, may help predict which patients are more likely to require surgical drainage. Laboratory parameters may not provide significant benefits in predicting the need for lymph node drainage and long-term treatment did not affect the treatment response.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burkholderia cepacia contaminating fresh frozen plasma causing transfusion transmitted bacterial infection. 伯克霍尔德氏菌污染新鲜冰冻血浆导致输血传播细菌感染。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-24 DOI: 10.1016/j.jiac.2024.10.013
Vithiya G, P Shunmuga Sundaram, T Rajendran

Bacterial contamination of plasma is unusual owing to frozen storage nevertheless reported. We report a case of transfusion transmitted infection due to Burkholderia cepacia contaminating fresh frozen plasma. A 31 year old male with decompensated chronic liver disease presented with breathlessness due to pleural effusion. Due to elevated prothrombin time, fresh frozen plasma was infused. After ten minutes of transfusion, he became febrile, tachypnoeic and transfusion was stopped. Plasma bag and blood cultures from patient grew B. cepacia. He became hemodynamically unstable due to underlying disease and died after a week.

由于冷冻储存的原因,血浆受到细菌污染的情况并不常见。我们报告了一例因新鲜冰冻血浆污染伯克霍尔德氏菌而导致的输血传播感染病例。一名患有慢性肝病失代偿期的 31 岁男性因胸腔积液出现呼吸困难。由于凝血酶原时间升高,他输注了新鲜冰冻血浆。输注 10 分钟后,他开始发热、心跳过速,输血随即停止。患者的血浆袋和血液培养物中都检出了头孢杆菌。由于潜在的疾病,他的血流动力学变得不稳定,一周后死亡。
{"title":"Burkholderia cepacia contaminating fresh frozen plasma causing transfusion transmitted bacterial infection.","authors":"Vithiya G, P Shunmuga Sundaram, T Rajendran","doi":"10.1016/j.jiac.2024.10.013","DOIUrl":"10.1016/j.jiac.2024.10.013","url":null,"abstract":"<p><p>Bacterial contamination of plasma is unusual owing to frozen storage nevertheless reported. We report a case of transfusion transmitted infection due to Burkholderia cepacia contaminating fresh frozen plasma. A 31 year old male with decompensated chronic liver disease presented with breathlessness due to pleural effusion. Due to elevated prothrombin time, fresh frozen plasma was infused. After ten minutes of transfusion, he became febrile, tachypnoeic and transfusion was stopped. Plasma bag and blood cultures from patient grew B. cepacia. He became hemodynamically unstable due to underlying disease and died after a week.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of switching to dolutegravir/lamivudine from tenofovir alafenamide fumarate/emtricitabine/dolutegravir or abacavir/lamivudine/dolutegravir on body weight and lipid profile in Japanese people living with HIV. 日本艾滋病病毒感染者从替诺福韦-阿拉非那胺富马酸盐/艾曲他滨/多罗替拉韦或阿巴卡韦/拉米夫定/多罗替拉韦转用多罗替拉韦/拉米夫定对体重和血脂的影响。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-22 DOI: 10.1016/j.jiac.2024.10.012
Kenichi Ikegaya, Takashi Muramatsu, Ryoko Sekiya, Yusuke Sekine, Yuko Harada, Ryui Miyashita, Tomoko Yamaguchi, Akito Ichiki, Yushi Chikasawa, Masato Bingo, Mihoko Yotsumoto, Takeshi Hagiwara, Kagehiro Amano, Hironori Takeuchi, Ei Kinai

Background: The two-drug regimen of dolutegravir/lamivudine (DTG/3TC) is currently an optional antiretroviral therapy (ART). Despite its reported advantages on body weight and lipid profile, the same effects have not yet been reported for Asian population.

Methods: We conducted a single-center retrospective study involving Japanese people living with HIV (PLWH). They were divided into four groups: those who had received abacavir/lamivudine/dolutegravir (ABC/3TC/DTG) and continued the same (ABC-ON group) or switched to DTG/3TC (ABC-OFF group), those who had received tenofovir alafenamide fumarate/emtricitabine/dolutegravir (TAF/FTC/DTG) and continued the same (TAF-ON group) or switched to DTG/3TC (TAF-OFF group). We compared changes in viral load, CD4⁺ cell count, CD4⁺/CD8⁺ ratio, body weight, BMI, lipid profiles, estimated glomerular filtration rate (eGFR), and fibrosis index based on four factors (FIB4-index) between the pre-switch and post-switch period.

Results: Of the 541 PLWH on DTG-based ART, 165, 94, 264 and 18 constituted the ABC-ON, ABC-OFF, TAF-ON, and TAF-OFF groups, respectively. Neither viral rebound nor CD4+decline was observed in the post-switch period in all groups. Multivariate analysis showed significant reduction in total cholesterol, LDL-C and HDL-C in the ABC-OFF group (-6.280, -6.957 and -2.268, p = 0.040, 0.012 and 0.022, respectively), but not in the TAF-OFF group (-3.000, 6.708 and 0.046, p = 0.607, 0.276 and 0.983, respectively). No significant changes were observed in body weight, eGFR, or FIB4-index at 72 weeks after the discontinuation of ABC or TAF.

Conclusions: Switching from ABC/3TC/DTG to DTG/3TC lowered lipids significantly, but not with TAF/FTC/DTG. Neither switch affected body weight or other markers.

背景:多罗替拉韦/拉米夫定(DTG/3TC)双药方案是目前可选的抗逆转录病毒疗法(ART)。尽管有报道称多鲁曲韦/拉米夫定双药方案对体重和血脂具有优势,但尚未有报道称亚洲人群也能获得同样的效果:我们进行了一项涉及日本 HIV 感染者(PLWH)的单中心回顾性研究。他们被分为四组:接受过阿巴卡韦/拉米夫定/度曲替韦(ABC/3TC/DTG)治疗并继续治疗(ABC-ON 组)或改用 DTG/3TC 治疗(ABC-OFF 组)的患者;接受过替诺福韦阿拉非酰胺烟酸/恩曲他滨/度曲替韦(TAF/FTC/DTG)治疗并继续治疗(TAF-ON 组)或改用 DTG/3TC 治疗(TAF-OFF 组)的患者。我们比较了切换前和切换后期间病毒载量、CD4⁺细胞计数、CD4⁺/CD8⁺比率、体重、体重指数、血脂概况、估计肾小球滤过率(eGFR)和基于四个因子的纤维化指数(FIB4-index)的变化:在接受以 DTG 为基础的抗逆转录病毒疗法的 541 名 PLWH 中,ABC-ON 组、ABC-OFF 组、TAF-ON 组和 TAF-OFF 组的人数分别为 165 人、94 人、264 人和 18 人。所有组别在切换后均未见病毒反弹或 CD4+ 下降。多变量分析显示,ABC-OFF 组的总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇显著下降(分别为-6.280、-6.957 和-2.268,p= 0.040、0.012 和 0.022),但 TAF-OFF 组没有显著下降(分别为-3.000、6.708 和 0.046,p= 0.607、0.276 和 0.983)。停用ABC或TAF 72周后,体重、eGFR或FIB4-指数未见明显变化:结论:从 ABC/3TC/DTG 转为 DTG/3TC 能显著降低血脂,但 TAF/FTC/DTG 则不能。两种药物的转换都不会影响体重或其他指标。
{"title":"Effects of switching to dolutegravir/lamivudine from tenofovir alafenamide fumarate/emtricitabine/dolutegravir or abacavir/lamivudine/dolutegravir on body weight and lipid profile in Japanese people living with HIV.","authors":"Kenichi Ikegaya, Takashi Muramatsu, Ryoko Sekiya, Yusuke Sekine, Yuko Harada, Ryui Miyashita, Tomoko Yamaguchi, Akito Ichiki, Yushi Chikasawa, Masato Bingo, Mihoko Yotsumoto, Takeshi Hagiwara, Kagehiro Amano, Hironori Takeuchi, Ei Kinai","doi":"10.1016/j.jiac.2024.10.012","DOIUrl":"10.1016/j.jiac.2024.10.012","url":null,"abstract":"<p><strong>Background: </strong>The two-drug regimen of dolutegravir/lamivudine (DTG/3TC) is currently an optional antiretroviral therapy (ART). Despite its reported advantages on body weight and lipid profile, the same effects have not yet been reported for Asian population.</p><p><strong>Methods: </strong>We conducted a single-center retrospective study involving Japanese people living with HIV (PLWH). They were divided into four groups: those who had received abacavir/lamivudine/dolutegravir (ABC/3TC/DTG) and continued the same (ABC-ON group) or switched to DTG/3TC (ABC-OFF group), those who had received tenofovir alafenamide fumarate/emtricitabine/dolutegravir (TAF/FTC/DTG) and continued the same (TAF-ON group) or switched to DTG/3TC (TAF-OFF group). We compared changes in viral load, CD4⁺ cell count, CD4⁺/CD8⁺ ratio, body weight, BMI, lipid profiles, estimated glomerular filtration rate (eGFR), and fibrosis index based on four factors (FIB4-index) between the pre-switch and post-switch period.</p><p><strong>Results: </strong>Of the 541 PLWH on DTG-based ART, 165, 94, 264 and 18 constituted the ABC-ON, ABC-OFF, TAF-ON, and TAF-OFF groups, respectively. Neither viral rebound nor CD4<sup>+</sup>decline was observed in the post-switch period in all groups. Multivariate analysis showed significant reduction in total cholesterol, LDL-C and HDL-C in the ABC-OFF group (-6.280, -6.957 and -2.268, p = 0.040, 0.012 and 0.022, respectively), but not in the TAF-OFF group (-3.000, 6.708 and 0.046, p = 0.607, 0.276 and 0.983, respectively). No significant changes were observed in body weight, eGFR, or FIB4-index at 72 weeks after the discontinuation of ABC or TAF.</p><p><strong>Conclusions: </strong>Switching from ABC/3TC/DTG to DTG/3TC lowered lipids significantly, but not with TAF/FTC/DTG. Neither switch affected body weight or other markers.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High plasma concentration of tenofovir alafenamide in people living with HIV with ABCB1 genetic variants. 具有 ABCB1 基因变异的 HIV 感染者体内替诺福韦-阿拉非那胺的血浆浓度较高。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-18 DOI: 10.1016/j.jiac.2024.10.009
Kiyoto Tsuchiya, Hieu Trung Tran, Akira Kawashima, Koji Watanabe, Akinobu Hamada, Shinichi Oka, Hiroyuki Gatanaga

Objectives: We aimed to analyze the relationships between single nucleotide polymorphisms in the ATP-binding cassette transporter B1 (ABCB1) and G2 (ABCG2) genes and plasma concentrations of tenofovir alafenamide (TAF), tenofovir (TFV), and emtricitabine (FTC).

Methods: We recruited 10 people living with HIV receiving once-daily treatment with a single tablet containing TAF (25 mg), FTC (200 mg), and bictegravir (50 mg). Peripheral blood samples were collected at 0, 1, 2, 3, 4, 6, 8, 12, and 24 h after administration. Plasma concentrations of TAF, TFV, and FTC were quantified using liquid chromatography-tandem mass spectrometry. Genotyping for allelic variants of ABCB1, including 1236C > T (rs1128503), 2677 G > T/A (rs2032582), 3435C > T (rs1045642), 4036 A > G (rs3842) and ABCG2 421C > A (rs2231142), was performed using TaqMan Drug Metabolism Assays.

Results: None of the genotypes for ABCB1 1236C > T, 2677 G > T/A, 3435C > T, and ABCG2 421C > A exhibited correlations with plasma concentrations of TAF, TFV, and FTC. In contrast, individuals with the ABCB1 4036 AG genotype (188.7 ng/mL, n = 3) exhibited a significantly higher mean peak plasma concentration of TAF than those with the ABCB1 4036 AA genotype (67.7 ng/mL, n = 7) (p = 0.0167). However, these genotypes did not affect the elimination of terminal half-lives of TAF.

Conclusions: The allelic variant ABCB1 4036 A > G is associated with reduced protein expression and function of ABCB1. Individuals with this genetic variant exhibited significantly high peak plasma concentrations of TAF, potentially due to the reduced expression of efflux transporters in the intestines linked to this variant.

研究目的我们旨在分析ATP结合盒转运体B1(ABCB1)和G2(ABCG2)基因的单核苷酸多态性与替诺福韦-阿拉非那胺(TAF)、替诺福韦(TFV)和恩曲他滨(FTC)血浆浓度之间的关系:我们招募了 10 名艾滋病病毒感染者,他们每天接受一次含 TAF(25 毫克)、FTC(200 毫克)和 bictegravir(50 毫克)的片剂治疗。在服药后 0、1、2、3、4、6、8、12 和 24 小时采集外周血样本。采用液相色谱-串联质谱法对血浆中 TAF、TFV 和 FTC 的浓度进行定量。使用 TaqMan 药物代谢测定法对 ABCB1 的等位基因变异进行了基因分型,包括 1236 C>T (rs1128503)、2677 G>T/A (rs2032582)、3435 C>T (rs1045642)、4036 A>G (rs3842) 和 ABCG2 421 C>A (rs2231142):结果:ABCB1 1236 C>T、2677 G>T/A、3435 C>T和ABCG2 421 C>A的基因型均与TAF、TFV和FTC的血浆浓度无关。相比之下,ABCB1 4036 AG 基因型个体(188.7 纳克/毫升,n = 3)的 TAF 平均血浆峰值浓度明显高于 ABCB1 4036 AA 基因型个体(67.7 纳克/毫升,n = 7)(p = 0.0167)。然而,这些基因型并不影响 TAF 末端半衰期的消除:结论:等位基因变体 ABCB1 4036 A>G 与 ABCB1 蛋白表达和功能降低有关。具有该基因变异的个体血浆中 TAF 的峰值浓度明显较高,这可能是由于与该变异相关的肠道中外排转运体的表达减少所致。
{"title":"High plasma concentration of tenofovir alafenamide in people living with HIV with ABCB1 genetic variants.","authors":"Kiyoto Tsuchiya, Hieu Trung Tran, Akira Kawashima, Koji Watanabe, Akinobu Hamada, Shinichi Oka, Hiroyuki Gatanaga","doi":"10.1016/j.jiac.2024.10.009","DOIUrl":"10.1016/j.jiac.2024.10.009","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to analyze the relationships between single nucleotide polymorphisms in the ATP-binding cassette transporter B1 (ABCB1) and G2 (ABCG2) genes and plasma concentrations of tenofovir alafenamide (TAF), tenofovir (TFV), and emtricitabine (FTC).</p><p><strong>Methods: </strong>We recruited 10 people living with HIV receiving once-daily treatment with a single tablet containing TAF (25 mg), FTC (200 mg), and bictegravir (50 mg). Peripheral blood samples were collected at 0, 1, 2, 3, 4, 6, 8, 12, and 24 h after administration. Plasma concentrations of TAF, TFV, and FTC were quantified using liquid chromatography-tandem mass spectrometry. Genotyping for allelic variants of ABCB1, including 1236C > T (rs1128503), 2677 G > T/A (rs2032582), 3435C > T (rs1045642), 4036 A > G (rs3842) and ABCG2 421C > A (rs2231142), was performed using TaqMan Drug Metabolism Assays.</p><p><strong>Results: </strong>None of the genotypes for ABCB1 1236C > T, 2677 G > T/A, 3435C > T, and ABCG2 421C > A exhibited correlations with plasma concentrations of TAF, TFV, and FTC. In contrast, individuals with the ABCB1 4036 AG genotype (188.7 ng/mL, n = 3) exhibited a significantly higher mean peak plasma concentration of TAF than those with the ABCB1 4036 AA genotype (67.7 ng/mL, n = 7) (p = 0.0167). However, these genotypes did not affect the elimination of terminal half-lives of TAF.</p><p><strong>Conclusions: </strong>The allelic variant ABCB1 4036 A > G is associated with reduced protein expression and function of ABCB1. Individuals with this genetic variant exhibited significantly high peak plasma concentrations of TAF, potentially due to the reduced expression of efflux transporters in the intestines linked to this variant.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three cases of infectious mononucleosis with concurrent false-positive non-treponemal and treponemal tests: Serological findings masquerading as syphilis. 三例传染性单核细胞增多症同时伴有非特异性和特异性试验假阳性:伪装成梅毒的血清学发现。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-17 DOI: 10.1016/j.jiac.2024.10.011
Naoki Matsuura

Biological false-positive reactions to non-treponemal syphilis tests occur under various conditions, including in patients with infectious mononucleosis. However, false-positive treponemal test results are rarely reported. We present three cases of Epstein-Barr virus-associated infectious mononucleosis that exhibited concurrent false-positive results in both treponemal and non-treponemal tests, effectively imitating syphilis serology. Notably, the false-positive treponemal test results were transient and persisted for more than 6 months before reverting to negative. This is atypical for true Treponema pallidum infection (syphilis), in which treponemal tests usually remain positive for life. This case series highlights the potential for misdiagnosis and emphasizes the importance of careful interpretation of syphilis serology results in the context of infectious mononucleosis. This is particularly important when typical syphilis symptoms are absent, as in our patients. The similarity in the clinical manifestations between infectious mononucleosis and syphilis, including sore throat, lymphadenopathy, rash, and hepatitis, further complicates the diagnostic process. Clinicians should consider recent Epstein-Barr virus-associated infectious mononucleosis when interpreting positive syphilis serology, especially in young adults presenting with mononucleosis-like symptoms. Follow-up serological testing is useful to avoid unnecessary treatment and potential patient mismanagement.

在各种情况下,包括在传染性单核细胞增多症患者中,都会出现非三阳梅毒检测的生物假阳性反应。然而,梅毒检测结果呈假阳性的报道却很少见。我们介绍了三例与爱泼斯坦-巴氏病毒相关的传染性单核细胞增多症病例,这些病例的梅毒螺旋体检测和非螺旋体检测结果同时呈假阳性,有效地模仿了梅毒血清学检测。值得注意的是,梅毒螺旋体检测的假阳性结果是一过性的,持续了 6 个多月才转为阴性。这种情况在真正的苍白螺旋体感染(梅毒)中并不典型,在梅毒感染中,三螺旋体检测结果通常终身呈阳性。这组病例突出了误诊的可能性,并强调了在传染性单核细胞增多症的背景下仔细解读梅毒血清学结果的重要性。当梅毒患者没有典型梅毒症状时,这一点尤为重要。传染性单核细胞增多症和梅毒的临床表现相似,包括咽痛、淋巴结病、皮疹和肝炎,这使得诊断过程更加复杂。临床医生在解读梅毒血清学阳性结果时,应考虑近期出现的与爱泼斯坦-巴氏病毒相关的传染性单核细胞增多症,尤其是出现类似单核细胞增多症症状的年轻成人。后续血清学检测有助于避免不必要的治疗和潜在的患者管理不当。
{"title":"Three cases of infectious mononucleosis with concurrent false-positive non-treponemal and treponemal tests: Serological findings masquerading as syphilis.","authors":"Naoki Matsuura","doi":"10.1016/j.jiac.2024.10.011","DOIUrl":"10.1016/j.jiac.2024.10.011","url":null,"abstract":"<p><p>Biological false-positive reactions to non-treponemal syphilis tests occur under various conditions, including in patients with infectious mononucleosis. However, false-positive treponemal test results are rarely reported. We present three cases of Epstein-Barr virus-associated infectious mononucleosis that exhibited concurrent false-positive results in both treponemal and non-treponemal tests, effectively imitating syphilis serology. Notably, the false-positive treponemal test results were transient and persisted for more than 6 months before reverting to negative. This is atypical for true Treponema pallidum infection (syphilis), in which treponemal tests usually remain positive for life. This case series highlights the potential for misdiagnosis and emphasizes the importance of careful interpretation of syphilis serology results in the context of infectious mononucleosis. This is particularly important when typical syphilis symptoms are absent, as in our patients. The similarity in the clinical manifestations between infectious mononucleosis and syphilis, including sore throat, lymphadenopathy, rash, and hepatitis, further complicates the diagnostic process. Clinicians should consider recent Epstein-Barr virus-associated infectious mononucleosis when interpreting positive syphilis serology, especially in young adults presenting with mononucleosis-like symptoms. Follow-up serological testing is useful to avoid unnecessary treatment and potential patient mismanagement.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carbon dioxide-dependent, extended-spectrum β-lactamase producing Escherichia coli bacteremia associated with pyelonephritis: A case-report. 二氧化碳依赖性广谱β-内酰胺酶产生的大肠埃希菌菌血症伴肾盂肾炎:病例报告。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-16 DOI: 10.1016/j.jiac.2024.10.010
Shinya Yamamoto, Tatsuya Kobayashi, Mahoko Ikeda, Yusuke Nomura, Takeru Morishige, Katsuhiro Makino, Hiroshi Ito, Marie Yamashita, Daisuke Jubishi, Yoshiaki Kanno, Koh Okamoto, Yoshimi Higurashi, Shu Okugawa, Kyoji Moriya, Haruki Kume, Takeya Tsutsumi

Escherichia coli is a facultative anaerobic bacterium that causes urinary tract and bloodstream infections. Generally, E. coli is easily identified in routine clinical microbiology laboratories. Herein, we report a case of pyelonephritis with bacteremia due to extended-spectrum β-lactamase (ESBL) producing E. coli, which delayed the identification of the isolate as it exhibited carbon dioxide (CO2)-dependent growth. The patient was a 62-year-old man who presented with nausea and an altered mental status. Contrast-enhanced computed tomography revealed multiple abscesses in the left kidney. The anaerobic bottles of the two sets of blood cultures were positive, but growth on a routine aerobic culture was weak. Identification of the isolate was delayed because it grew only on agar plates incubated in a 5 % CO2 atmosphere. The isolate was suspected to be an ESBL-producing strain based on antimicrobial susceptibility testing, which was confirmed by polymerase chain reaction analysis. The patient was successfully treated with administering meropenem and nephrectomy. To the best-of-our-knowledge, this is the first reported case of a human infection caused by ESBL-producing carbon-dioxide-dependent E. coli.

大肠杆菌是一种兼性厌氧细菌,可引起尿路和血液感染。一般来说,大肠杆菌很容易在常规临床微生物实验室中被鉴定出来。在此,我们报告了一例由产广谱β-内酰胺酶(ESBL)大肠杆菌引起的肾盂肾炎并伴有菌血症的病例,由于大肠杆菌表现出二氧化碳(CO2)依赖性生长,因此延误了对分离菌的鉴定。患者是一名 62 岁的男性,出现恶心和精神状态改变。对比增强计算机断层扫描显示左肾有多处脓肿。两组血液培养的厌氧瓶均呈阳性,但常规需氧培养的生长很弱。由于分离菌只在 5% CO2 环境下培养的琼脂平板上生长,因此鉴定工作被推迟。根据抗菌药敏感性检测结果,怀疑该分离菌株为产 ESBL 菌株,聚合酶链反应分析证实了这一点。通过使用美罗培南和肾切除术,患者得到了成功治疗。据我们所知,这是首例报告的由产 ESBL 二氧化碳依赖性大肠杆菌引起的人类感染病例。
{"title":"Carbon dioxide-dependent, extended-spectrum β-lactamase producing Escherichia coli bacteremia associated with pyelonephritis: A case-report.","authors":"Shinya Yamamoto, Tatsuya Kobayashi, Mahoko Ikeda, Yusuke Nomura, Takeru Morishige, Katsuhiro Makino, Hiroshi Ito, Marie Yamashita, Daisuke Jubishi, Yoshiaki Kanno, Koh Okamoto, Yoshimi Higurashi, Shu Okugawa, Kyoji Moriya, Haruki Kume, Takeya Tsutsumi","doi":"10.1016/j.jiac.2024.10.010","DOIUrl":"https://doi.org/10.1016/j.jiac.2024.10.010","url":null,"abstract":"<p><p>Escherichia coli is a facultative anaerobic bacterium that causes urinary tract and bloodstream infections. Generally, E. coli is easily identified in routine clinical microbiology laboratories. Herein, we report a case of pyelonephritis with bacteremia due to extended-spectrum β-lactamase (ESBL) producing E. coli, which delayed the identification of the isolate as it exhibited carbon dioxide (CO<sub>2</sub>)-dependent growth. The patient was a 62-year-old man who presented with nausea and an altered mental status. Contrast-enhanced computed tomography revealed multiple abscesses in the left kidney. The anaerobic bottles of the two sets of blood cultures were positive, but growth on a routine aerobic culture was weak. Identification of the isolate was delayed because it grew only on agar plates incubated in a 5 % CO<sub>2</sub> atmosphere. The isolate was suspected to be an ESBL-producing strain based on antimicrobial susceptibility testing, which was confirmed by polymerase chain reaction analysis. The patient was successfully treated with administering meropenem and nephrectomy. To the best-of-our-knowledge, this is the first reported case of a human infection caused by ESBL-producing carbon-dioxide-dependent E. coli.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptoms of post COVID-19 condition and diseases/conditions diagnosed after COVID-19 in Japanese patients: A real-world study using a claims database. 日本患者 COVID-19 后的症状以及 COVID-19 后诊断出的疾病/病症:利用索赔数据库进行的真实世界研究。
IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-11 DOI: 10.1016/j.jiac.2024.10.008
Satoshi Kutsuna, Ryotaro Tajima, Genta Ito, Takuji Komeda, Hideyuki Miyauchi, Yoshitake Kitanishi

Background: More than 200 symptoms of post coronavirus disease (COVID-19) condition (PCC) impacting patients' quality of life have been reported. This study describes the symptoms of well-known PCC and diseases/conditions diagnosed after COVID-19 and analyzes the trends in well-known PCC according to the epidemic waves in the Japanese population.

Methods: Patients with a COVID-19 diagnosis in the JMDC claims database were matched 1:1 with individuals without COVID-19 diagnosis (controls) based on sex, year and month of birth, and risk factors for aggravation. The first month of COVID-19 diagnosis from January 2020-March 2022 was the index month, and the observation period was from July 2019 to 6 months from the index month (patients) and July 2019-September 2022 (controls).

Results: Of 263,456 each of patients and controls after matching, 51.8 % were aged 18-49 years, 56.3 % were male, and 24.5 % had risk factors for aggravation. One in 18 patients experienced well-known PCC 2-3 months after severe acute respiratory syndrome cornonavirus 2 infection, with the highest odds ratio (OR) being for pulmonary thromboembolism (29.37), followed by smell/taste disorder (13.34) and respiratory failure (8.28). Some of the common diseases/conditions diagnosed after COVID-19 comprised those of the genitourinary system, eye and adnexa, and ear and mastoid process and certain infectious and parasitic diseases. Overall, the risk difference decreased from the first to the sixth wave, but the OR was >1.00 for most symptoms even during the sixth wave.

Conclusions: PCC symptoms showed a declining trend over time but persisted. Physicians and patients need to recognize PCC symptoms.

背景:已有 200 多种影响患者生活质量的 COVID-19 后疾病(PCC)症状被报道。本研究描述了知名 PCC 的症状和 COVID-19 诊断后的疾病/病症,并根据日本人口中的流行病浪潮分析了知名 PCC 的趋势:方法:根据性别、出生年份和月份以及病情恶化的风险因素,将日本疾病预防控制中心索赔数据库中确诊为冠状病毒疾病(COVID-19)的患者与未确诊为 COVID-19 的患者(对照组)进行 1:1 配对。2020年1月至2022年3月期间诊断出COVID-19的第一个月为指标月,观察期为2019年7月至指标月起的6个月(患者)和2019年7月至2022年9月(对照组):在配对后的263 456名患者和对照组中,51.8%的患者年龄在18-49岁之间,56.3%为男性,24.5%存在病情加重的风险因素。每 18 名患者中就有 1 人在感染 SARS-CoV-2 2-3 个月后出现知名的 PCC,其中肺血栓栓塞症的几率比(OR)最高(29.37),其次是嗅觉/味觉障碍(13.34)和呼吸衰竭(8.28)。COVID-19 后诊断出的一些常见疾病/病症包括泌尿生殖系统、眼睛和附件、耳和乳突以及某些传染病和寄生虫病。总体而言,从第一波到第六波,风险差异有所减小,但即使在第六波中,大多数症状的 OR 也大于 1.00:结论:随着时间的推移,PCC 症状呈下降趋势,但仍持续存在。医生和患者需要识别 PCC 症状。
{"title":"Symptoms of post COVID-19 condition and diseases/conditions diagnosed after COVID-19 in Japanese patients: A real-world study using a claims database.","authors":"Satoshi Kutsuna, Ryotaro Tajima, Genta Ito, Takuji Komeda, Hideyuki Miyauchi, Yoshitake Kitanishi","doi":"10.1016/j.jiac.2024.10.008","DOIUrl":"10.1016/j.jiac.2024.10.008","url":null,"abstract":"<p><strong>Background: </strong>More than 200 symptoms of post coronavirus disease (COVID-19) condition (PCC) impacting patients' quality of life have been reported. This study describes the symptoms of well-known PCC and diseases/conditions diagnosed after COVID-19 and analyzes the trends in well-known PCC according to the epidemic waves in the Japanese population.</p><p><strong>Methods: </strong>Patients with a COVID-19 diagnosis in the JMDC claims database were matched 1:1 with individuals without COVID-19 diagnosis (controls) based on sex, year and month of birth, and risk factors for aggravation. The first month of COVID-19 diagnosis from January 2020-March 2022 was the index month, and the observation period was from July 2019 to 6 months from the index month (patients) and July 2019-September 2022 (controls).</p><p><strong>Results: </strong>Of 263,456 each of patients and controls after matching, 51.8 % were aged 18-49 years, 56.3 % were male, and 24.5 % had risk factors for aggravation. One in 18 patients experienced well-known PCC 2-3 months after severe acute respiratory syndrome cornonavirus 2 infection, with the highest odds ratio (OR) being for pulmonary thromboembolism (29.37), followed by smell/taste disorder (13.34) and respiratory failure (8.28). Some of the common diseases/conditions diagnosed after COVID-19 comprised those of the genitourinary system, eye and adnexa, and ear and mastoid process and certain infectious and parasitic diseases. Overall, the risk difference decreased from the first to the sixth wave, but the OR was >1.00 for most symptoms even during the sixth wave.</p><p><strong>Conclusions: </strong>PCC symptoms showed a declining trend over time but persisted. Physicians and patients need to recognize PCC symptoms.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection and Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1